Magnus Unemo
Magnus Unemo is a prominent researcher at Örebro University in Sweden, known for his work on antimicrobial resistance in Neisseria gonorrhoeae. He contributed to the commentary accompanying a study on gepotidacin, emphasizing the potential for the drug to face resistance as well, and the need for ongoing development of additional treatments for gonorrhea.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 5.00 | 0.03% | +0% | 331,002,651 | 99,760 | $21,000,000 | 6,329$ |
| Canada | 1 | 6.00 | 0.06% | +0% | 38,005,238 | 22,595 | $1,700,000 | 1,011$ |
| Totals | 2 | 369,007,889 | 122,355 | $22,700,000 | 7,340$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Magnus Unemo is a researcher who wrote in a Lancet editorial about the potential for N. gonorrhoeae to develop gepotidacin resistance.
6
United States:
Magnus Unemo is from Örebro University in Sweden and commented on the potential resistance of gonorrhea to gepotidacin.
5